Beam Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 12.47 M | $345.59 M | 12.94% | 12.15% |
| FMR LLC | 02/17/2026 | 11.91 M | $330.12 M | 1.85% | 11.61% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 10.06 M | $278.95 M | 0.00% | 9.81% |
| VANGUARD GROUP INC | 01/29/2026 | 9.19 M | $254.84 M | -0.62% | 8.96% |
| BLACKROCK, INC. | 02/12/2026 | 8.45 M | $234.24 M | 3.71% | 8.24% |
| STATE STREET CORP | 02/13/2026 | 5.23 M | $144.93 M | 30.43% | 5.10% |
| ARCH VENTURE MANAGEMENT, LLC | 02/17/2026 | 4.54 M | $125.85 M | 0.00% | 4.43% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 4.41 M | $122.23 M | -8.72% | 4.30% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/11/2026 | 4.41 M | $122.18 M | -8.72% | 4.30% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 2.73 M | $75.68 M | 20.64% | 2.66% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 2.44 M | $67.64 M | -3.08% | 2.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.35 M | $65.21 M | -1.63% | 2.29% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.95 M | $54.00 M | 13.23% | 1.90% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 1.71 M | $47.47 M | 2.82% | 1.67% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 1.60 M | $44.35 M | 0.00% | 1.56% |
| REDMILE GROUP, LLC | 02/17/2026 | 1.29 M | $35.64 M | -7.33% | 1.25% |
| 02/17/2026 | 1.27 M | $35.12 M | 100.00% | 1.24% | |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.12 M | $31.06 M | 195.58% | 1.09% |
| WOODLINE PARTNERS LP | 02/17/2026 | 993.07 K | $27.53 M | 81.69% | 0.97% |
| UBS GROUP AG | 01/29/2026 | 973.84 K | $26.99 M | -14.40% | 0.95% |
| MARSHALL WACE, LLP | 02/13/2026 | 945.83 K | $26.22 M | 100.00% | 0.92% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 937.00 K | $25.97 M | 100.00% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 834.80 K | $23.14 M | -0.76% | 0.81% |
| NORTHERN TRUST CORP | 02/17/2026 | 808.95 K | $22.42 M | -5.31% | 0.79% |
| MORGAN STANLEY | 02/13/2026 | 729.40 K | $20.22 M | 13.13% | 0.71% |
| JPMORGAN CHASE & CO | 02/11/2026 | 619.24 K | $17.17 M | 14.40% | 0.60% |
| RTW INVESTMENTS, LP | 02/17/2026 | 570.39 K | $15.81 M | 100.00% | 0.56% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 550.00 K | $15.25 M | 37.50% | 0.54% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 02/12/2026 | 533.56 K | $14.79 M | 39.12% | 0.52% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 532.50 K | $14.76 M | 475.68% | 0.52% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 527.80 K | $14.63 M | 58.50% | 0.51% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 522.64 K | $14.49 M | -60.37% | 0.51% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 500.20 K | $13.87 M | 66.84% | 0.49% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 492.43 K | $13.65 M | -60.92% | 0.48% |
| 02/17/2026 | 476.34 K | $13.20 M | 100.00% | 0.46% | |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 468.91 K | $13.00 M | 1,856.24% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 427.33 K | $11.85 M | -45.15% | 0.42% |
| BAILLIE GIFFORD & CO | 01/23/2026 | 416.22 K | $11.54 M | 39.76% | 0.41% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 399.66 K | $11.08 M | 467.45% | 0.39% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 357.67 K | $9.91 M | -12.64% | 0.35% |
| BARCLAYS PLC | 02/13/2026 | 326.18 K | $9.04 M | 4.00% | 0.32% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 325.65 K | $9.06 M | -3.51% | 0.32% |
| ALPHABET INC. | 02/13/2026 | 321.60 K | $8.91 M | 0.00% | 0.31% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 301.65 K | $8.36 M | 913.95% | 0.29% |
| PEREGRINE INVESTMENT MANAGEMENT INC | 02/04/2026 | 257.28 K | $7.13 M | -3.97% | 0.25% |
| CITADEL ADVISORS LLC | 02/17/2026 | 255.71 K | $7.09 M | 100.00% | 0.25% |
| NUVEEN, LLC | 02/12/2026 | 233.07 K | $6.46 M | -1.80% | 0.23% |
| CITADEL ADVISORS LLC | 02/17/2026 | 218.90 K | $6.07 M | -16.42% | 0.21% |
| INVESCO LTD. | 02/19/2026 | 213.19 K | $5.91 M | 20.54% | 0.21% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2026 | 196.04 K | $5.43 M | 17.88% | 0.19% |
Beam Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 335 institutional investors and hedge funds held shares of Beam Therapeutics Inc. The most heavily invested institutionals were:
ARK Investment Management LLC: 12.13 M
Nikko Asset Management Americas, Inc.: 3.83 M
Sumitomo Mitsui Trust Holdings, Inc.: 3.83 M
DIMENSIONAL FUND ADVISORS LP: 2.15 M
UBS Group AG: 826,061
BNP PARIBAS ARBITRAGE, SNC: 700,647
104.18% of Beam Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 129.60 M shares in the last 24 months. This purchase volume represents approximately $3.58 B in transactions.